Depression-like and anxiety-like behavioural aftermaths of impact accelerated traumatic brain injury in rats: A model of comorbid depression and anxiety?

被引:83
作者
Pandey, Dilip Kumar [1 ]
Yadav, Sushil Kumar [2 ]
Mahesh, Radhakrishnan [1 ]
Rajkumar, Ramamoorthy [1 ]
机构
[1] Birla Inst Technol & Sci, Pharm Grp, FD III, Pilani 333031, Rajasthan, India
[2] Birla Inst Technol & Sci, Cent Anim Facil, Pilani 333031, Rajasthan, India
关键词
Traumatic brain injury; Comorbid; Depression; Anxiety; Behavioural test battery; Escitalopram; SEROTONIN REUPTAKE INHIBITOR; OLFACTORY BULBECTOMIZED RAT; MARBLE-BURYING BEHAVIOR; ELEVATED PLUS-MAZE; MAJOR DEPRESSION; ANIMAL-MODELS; AMYGDALOID-LESIONS; SOCIAL-INTERACTION; SEXUAL-BEHAVIOR; HEAD-INJURY;
D O I
10.1016/j.bbr.2009.07.027
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Depression and anxiety tend to be the most prevalent conditions among the multitude of neurobehavioural disorders which cause distress in the survivors of traumatic brain injury (TBI) The objective of the present investigation was to examine depression-like and anxiety-like behaviour of rats following diffuse TBI Impact accelerated TBI was induced in anaesthetised rats by a modified weight drop method. TBI and sham-operated rats received either a chronic (14 days) regimen of escitalopram (5-20 mg/kg) or vehicle, following which they were subjected to a behavioural test battery. The results evince the depression-like behaviour of TBI rats in modified open field exploration. hyperemotionality. socio-sexual interaction and elevated plus-maze exploration paradigms. In addition. an anxiety-like behaviour was evident in social interaction and marble-burying tests Chronic escitalopram (10 and 20 mg/kg) treatment significantly attenuated the TBI associated behavioural deficits. In conclusion, the aforesaid behavioural anomalies observed in TBI rats are analogous to comorbid anxiety and depression in humans. These findings substantiate the TBI rats as a candidate model of comorbid anxiety and depression. (C) 2009 Elsevier B V All rights reserved.
引用
收藏
页码:436 / 442
页数:7
相关论文
共 94 条
[1]  
*AM PSYCH ASS, 2000, TEXT REV, P780
[2]  
Andrews G, 2000, B WORLD HEALTH ORGAN, V78, P446
[3]   Reduced plasma levels of tyrosine, precursor of brain catecholamines, and of essential amino acids in patients with severe traumatic brain injury after rehabilitation [J].
Aquilani, R ;
Iadarola, P ;
Boschi, F ;
Pistarini, C ;
Arcidiaco, P ;
Contardi, A .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2003, 84 (09) :1258-1265
[4]   The use of escitalopram beyond major depression: Pharmacological aspects, efficacy and tolerability in anxiety disorders [J].
Bareggi, Silvio R. ;
Mundo, Emanuela ;
Dell'Osso, Bernardo ;
Altamura, A. Carlo .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2007, 3 (05) :741-753
[5]  
BRITTON A, 1988, BRAIN INJURY, V12, P703
[6]   MAJOR TRANQUILIZERS CAN BE DISTINGUISHED FROM MINOR TRANQUILIZERS ON THE BASIS OF EFFECTS ON MARBLE BURYING AND SWIM-INDUCED GROOMING IN MICE [J].
BROEKKAMP, CL ;
RIJK, HW ;
JOLYGELOUIN, D ;
LLOYD, KL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 126 (03) :223-229
[7]   Technical aspects of an impact acceleration traumatic brain injury rat model with potential suitability for both microdialysis and PtiO2 monitoring [J].
Carré, E ;
Cantais, E ;
Darbin, O ;
Terrier, JP ;
Lonjon, M ;
Palmier, B ;
Risso, JJ .
JOURNAL OF NEUROSCIENCE METHODS, 2004, 140 (1-2) :23-28
[8]   Neural substrates of symptoms of depression following concussion in male athletes with persisting postconcussion symptoms [J].
Chen, Jen-Kai ;
Johnston, Karen M. ;
Petrides, Michael ;
Ptito, Alain .
ARCHIVES OF GENERAL PSYCHIATRY, 2008, 65 (01) :81-89
[9]   Nitric oxide in traumatic brain injury [J].
Cherian, L ;
Hlatky, R ;
Robertson, CS .
BRAIN PATHOLOGY, 2004, 14 (02) :195-201
[10]   Injury-induced alterations in CNS electrophysiology [J].
Cohen, Akiva S. ;
Pfister, Bryan J. ;
Schwarzbach, Elizabeth ;
Grady, M. Sean ;
Goforth, Paulette B. ;
Satin, Leslie S. .
NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT, 2007, 161 :143-169